The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.

Condition	Treatment or Intervention	Phase
Rhinitis, Allergic, Perennial	Drug: Investigational allergy drug	Phase III

Ages Eligible for Study:  2 Years   -   11 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Diagnosis of perennial allergic rhinitis.

Exclusion Criteria:

• Have significant concomitant medical conditions.
• Use of corticosteroids or other allergy medications during the study.
• Have abnormal ECG.
• Have laboratory abnormality.
• Have abnormal eye exam.

Please refer to this study by ClinicalTrials.gov identifier  NCT00108914

California
      Cudahy,  California,  90201,  United States; Recruiting
      Long Beach,  California,  90808,  United States; Recruiting
      San Diego,  California,  92120,  United States; Recruiting
      San Diego,  California,  92123,  United States; Recruiting
      San Diego,  California,  92131,  United States; Terminated
      Riverside,  California,  92805,  United States; Recruiting
      Orange,  California,  92868,  United States; Recruiting
      Walnut Creek,  California,  94598,  United States; Recruiting
      Sacramento,  California,  95819,  United States; Recruiting
Colorado
      Englewood,  Colorado,  80112,  United States; Recruiting
      Denver,  Colorado,  80206,  United States; Recruiting
      Fort Collins,  Colorado,  80526,  United States; Terminated
Florida
      Coral Gables,  Florida,  33134,  United States; Recruiting
Georgia
      Lawrenceville,  Georgia,  30045,  United States; Recruiting
      Stockbridge,  Georgia,  30281,  United States; Recruiting
      Gainesville,  Georgia,  30501,  United States; Recruiting
Louisiana
      Metairie,  Louisiana,  70006,  United States; Recruiting
      Shreveport,  Louisiana,  71105,  United States; Recruiting
Maryland
      Bethesda,  Maryland,  20814,  United States; Terminated
Massachusetts
      North Dartmouth,  Massachusetts,  02747,  United States; Terminated
Michigan
      Ypsilanti,  Michigan,  48197,  United States; Recruiting
Mississippi
      Jackson,  Mississippi,  39202,  United States; Recruiting
Missouri
      Kansas City,  Missouri,  64108-9898,  United States; Recruiting
Nebraska
      Omaha,  Nebraska,  68130,  United States; Recruiting
New Jersey
      Skillman,  New Jersey,  08558,  United States; Terminated
New York
      Cortland,  New York,  13045,  United States; Recruiting
      Liverpool,  New York,  13088,  United States; Recruiting
      Utica,  New York,  13502,  United States; Recruiting
      Rochester,  New York,  14618,  United States; Recruiting
North Carolina
      Raleigh,  North Carolina,  27607,  United States; Recruiting
Ohio
      Cincinnati,  Ohio,  45231,  United States; Recruiting
Oklahoma
      Oklahoma City,  Oklahoma,  73120,  United States; Recruiting
Pennsylvania
      Bellevue,  Pennsylvania,  15202,  United States; Recruiting
      Pittsburgh,  Pennsylvania,  15213,  United States; Terminated
      Pittsburgh,  Pennsylvania,  15241-1080,  United States; Recruiting
      Upland,  Pennsylvania,  19013,  United States; Recruiting
      Blue Bell,  Pennsylvania,  19422,  United States; Terminated
South Carolina
      Charleston,  South Carolina,  29407,  United States; Recruiting
Tennessee
      Nashville,  Tennessee,  37203,  United States; Recruiting
      Knoxville,  Tennessee,  37922,  United States; Recruiting
Texas
      San Antonio,  Texas,  78229,  United States; Terminated
      El Paso,  Texas,  79902,  United States; Recruiting
Argentina
      Rosario,  2000,  Argentina; Not yet recruiting
      Rosario,  2000,  Argentina; Not yet recruiting
      Santa Fe,  3000,  Argentina; Not yet recruiting
      9 de Julio,  B6500BWQ,  Argentina; Not yet recruiting
      Ciudad Autónoma de Buenos Aires,  C1121ABE,  Argentina; Not yet recruiting
Bulgaria
      Sofia,  1000/1527,  Bulgaria; Not yet recruiting
      Sofia,  1431/1000,  Bulgaria; Not yet recruiting
      Sofia,  1431/1000,  Bulgaria; Not yet recruiting
      Rousse,  7000,  Bulgaria; Not yet recruiting
Chile
      Vina del Mar,  Chile; Not yet recruiting
      Santiago,  Chile; Not yet recruiting
      Puente Alto/Santiago,  Chile; Not yet recruiting
Finland
      Turku,  20610,  Finland; Not yet recruiting
      Hameenkati, Lahti,  33200,  Finland; Not yet recruiting
      Nokia,  37100,  Finland; Not yet recruiting
      Joesnsuu,  80100,  Finland; Not yet recruiting
Italy
      Perugia Umbria,  06122,  Italy; Not yet recruiting
      Milano Lombardia,  20129,  Italy; Not yet recruiting
      Milano Lombardia,  20132,  Italy; Not yet recruiting
      Ascoli Piceno,  63100,  Italy; Not yet recruiting
      Bari, Pulgia,  70124,  Italy; Not yet recruiting
      Napoli,  80138,  Italy; Not yet recruiting
      Avellino,  83100,  Italy; Not yet recruiting
      Avellino,  83100,  Italy; Not yet recruiting
      Salerno, Campania,  84126,  Italy; Not yet recruiting
      Palermo,  90100,  Italy; Not yet recruiting
Mexico
      Monterrey,  06460,  Mexico; Not yet recruiting
      Mexico,  4530,  Mexico; Not yet recruiting
Slovakia
      Levoca,  05401,  Slovakia; Not yet recruiting
      Bratislava,  82106,  Slovakia; Not yet recruiting
      Nitra,  94901,  Slovakia; Not yet recruiting
      Banska Bystrica,  97401,  Slovakia; Not yet recruiting
South Africa
      Westville,  3630,  South Africa; Not yet recruiting
      Westville,  3630,  South Africa; Not yet recruiting
      Port Elizabeth,  6014,  South Africa; Not yet recruiting
      Cape Town,  7500,  South Africa; Not yet recruiting
      Cape Town,  7764,  South Africa; Not yet recruiting
      Cape Town,  7925,  South Africa; Not yet recruiting

Study ID Numbers:  FFR30008
Record last reviewed:  April 2005
Last Updated:  April 21, 2005
Record first received:  April 20, 2005
ClinicalTrials.gov Identifier:  NCT00108914
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-03